Characterization of a Canine Glioma Cell Line As Related to Established Experimental Brain Tumor Models

作者: N. G. Rainov , S. Koch , M. Sena-Esteves , M. E. Berens

DOI: 10.1093/JNEN/59.7.607

关键词:

摘要: A large animal tumor model for anaplastic glioma has been recently developed using immunotolerant allogeneic Beagle dogs and an established canine cell line, J3T. This offers advantages in terms of morphology similarity to human glioma. The present study was aimed at evaluating the biological characteristics J3T line as related experimental gene therapy studies. Furthermore, development brain tumors a xenogeneic immunodeficient SCID mouse investigated. It demonstrated that cultured cells can be efficiently infected by adenovirus (AV), herpes-simplex type I (HSV), or retrovirus (RV) vectors, well non-virus vectors such cationic liposome/DNA complexes. Thus, infectability transfectability, seem closer than 9L rodent gliosarcoma. Cytotoxicity selection antibiotics G418, puromycin, hygromycin on essentially resemble cytotoxicity seen with other lines, example, 9L, U87, U343. RV-mediated HSV-TK/GCV comparable LD50 TK-expressing control (non-expressing) treated Ganciclovir. Further, it proven are tumorigenic may grow heterotopically orthotopically host, mouse, although growth pattern these differ from invasive phenotype dog.

参考文章(29)
Herrlinger U, Breakefield Xo, Reznikoff G, Kramm Cm, Louis Dn, Finkelstein D, Yu Js, Dranoff G, Johnston Km, Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Cancer Gene Therapy. ,vol. 4, pp. 345- ,(1997)
Nikolai G Rainov, Christof M Kramm, Karen Aboody-Guterman, Chase M, Keisuke Ueki, David N Louis, GRt Harsh, A Chiocca, Xandra O Breakefield, Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Cancer Gene Therapy. ,vol. 3, pp. 99- 106 ,(1996)
F.W. Weber, F.W. Floeth, G. Reifenberger, J. Felsberg, A. Aulich, J.C.W. Kiwit, W.J. Bock, MRI characteristics and histological changes in glioblastoma after gene therapy. Frontiers of Radiation Therapy and Oncology. ,vol. 33, pp. 244- 252 ,(1999) , 10.1159/000061240
Nikolai G. Rainov, Claus Zimmer, Maureen Chase, Christof M. Kramm, E. Antonio Chiocca, Ralph Weissleder, Xandra O. Breakefield, Selective Uptake of Viral and Monocrystalline Particles Delivered Intra-Arterially to Experimental Brain Neoplasms Human Gene Therapy. ,vol. 6, pp. 1543- 1552 ,(1995) , 10.1089/HUM.1995.6.12-1543
Daniel L. Peterson, Peter J. Sheridan, Willis E. Brown, Animal models for brain tumors: historical perspectives and future directions Journal of Neurosurgery. ,vol. 80, pp. 865- 876 ,(1994) , 10.3171/JNS.1994.80.5.0865
S Andreansky, B He, J van Cott, J McGhee, JM Markert, GY Gillespie, B Roizman, RJ Whitley, Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins. Gene Therapy. ,vol. 5, pp. 121- 130 ,(1998) , 10.1038/SJ.GT.3300550
Masahiro Toda, Samuel D. Rabkin, Hidefumi Kojima, Robert L. Martuza, Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. Human Gene Therapy. ,vol. 10, pp. 385- 393 ,(1999) , 10.1089/10430349950018832